Treatment for hypertension, male in Latvia
Latvia: Treatment for hypertension, male was 44.5% in 2019. ▲ Rising
Treatment for hypertension, male in Latvia, 1990–2019
Source: World Health Organization's Global Health Observatory Data Repository. Measured in % of male adults ages 30-79 with hypertension.
Analysis
The most recent figure for treatment for hypertension, male in Latvia is 44.5%, measured in 2019. That is the highest value across all 30 years on record.
Compared with earlier readings it is up 1.6% on the previous year and up 20.3% over ten years.
Over the whole period, treatment for hypertension, male in Latvia peaked at 44.5% in 2019 and was at its lowest, 18.8%, in 1990.
That places Latvia 60th out of 192 countries with data for 2019, putting it in the middle of the range.
The long-run direction has been consistently rising across the 30 years of available data.
Treatment for hypertension, male in Latvia, year by year
| Year | % of male adults ages 30-79 with hypertension | Change |
|---|---|---|
| 1990 | 18.8% | — |
| 1991 | 19.7% | +4.8% |
| 1992 | 20.5% | +4.1% |
| 1993 | 21.4% | +4.4% |
| 1994 | 22.4% | +4.7% |
| 1995 | 23.4% | +4.5% |
| 1996 | 24.4% | +4.3% |
| 1997 | 25.4% | +4.1% |
| 1998 | 26.5% | +4.3% |
| 1999 | 27.5% | +3.8% |
| 2000 | 28.5% | +3.6% |
| 2001 | 29.5% | +3.5% |
| 2002 | 30.6% | +3.7% |
| 2003 | 31.6% | +3.3% |
| 2004 | 32.6% | +3.2% |
| 2005 | 33.5% | +2.8% |
| 2006 | 34.5% | +3.0% |
| 2007 | 35.3% | +2.3% |
| 2008 | 36.2% | +2.5% |
| 2009 | 37.0% | +2.2% |
| 2010 | 37.9% | +2.4% |
| 2011 | 38.7% | +2.1% |
| 2012 | 39.5% | +2.1% |
| 2013 | 40.2% | +1.8% |
| 2014 | 41.0% | +2.0% |
| 2015 | 41.7% | +1.7% |
| 2016 | 42.4% | +1.7% |
| 2017 | 43.1% | +1.7% |
| 2018 | 43.8% | +1.6% |
| 2019 | 44.5% | +1.6% |
Latvia compared with similar countries
- Latvia's 44.5% is below the median for high income countries, which is 47.6%, 93% of the median. (62 countries reporting)
- Latvia's 44.5% is below the median for Europe & Central Asia, which is 46.0%, 97% of the median. (49 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 23.0% | 18.8% | 27.5% | 10 |
| 2000s | 32.9% | 28.5% | 37.0% | 10 |
| 2010s | 41.3% | 37.9% | 44.5% | 10 |
Countries ranked near Latvia
More health data for Latvia
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.3876 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,593 deaths per 1,000 people (2090)
- Number of infants who die before age 1 4 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -6.17 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0202 units per person (2025)
- Population ages 00-04, male, annual growth rate -6.02 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is treatment for hypertension, male in Latvia?
- Treatment for hypertension, male in Latvia was 44.5% in 2019, according to World Health Organization's Global Health Observatory Data Repository.
- What is the highest treatment for hypertension, male recorded in Latvia?
- The highest recorded value was 44.5% in 2019.
- What is the lowest treatment for hypertension, male recorded in Latvia?
- The lowest recorded value was 18.8% in 1990.
- How does Latvia rank for treatment for hypertension, male?
- Latvia ranks 60th out of 192 countries with data for 2019.
- Is treatment for hypertension, male rising or falling in Latvia?
- Over the last ten years it is up 20.3%. The long-run trend across the full record is rising.
- Where does this Latvia data come from?
- The figures come from World Health Organization's Global Health Observatory Data Repository, published as part of Treatment for hypertension, male (% of male adults ages 30-79 with hypertension). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 30 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Treatment for hypertension, male, is the percentage of adults ages 30-79 with hypertension who were taking medicine for hypertension. Hypertension is defined as having systolic blood pressure =140 mmHg, diastolic blood pressure =90 mmHg, or taking medication for hypertension.